Wall Street closed mixed on Tuesday, with the Nasdaq falling 1.5% on tech weakness while the Dow Jones Industrial Average rose 0.7%. On the earnings front, John Wiley & Sons beat Q1 estimates, while Vince Holding stunned markets with a 37% rally despite missing on EPS.
Earnings Highlights: Wiley Beats, Vince Defies Gravity
John Wiley & Sons (WLY) reported EPS of $1.67 versus the $1.65 consensus estimate, a 1.2% positive surprise. Shares of the academic publishing and knowledge company rose 2.5% to close at $44.39.
Vince Holding Corp. (VNCE) delivered a major reversal: despite posting a loss of $0.16 per share versus the $0.13 loss expected (a 23% miss), shares of the fashion retailer surged 37.3% to $6.88. The move suggests investor optimism around the company's ongoing turnaround efforts.
La-Z-Boy (LZB) reported fiscal Q4 results after the close, with earnings estimated at $0.82 per share. The stock fell 4.6% during regular trading amid cautious expectations ahead of the release.
ICON PLC (ICLR) — the Irish clinical research organization — reported Q1 results after market close against an analyst consensus of $2.43 EPS. The stock edged down 1.6% during the session.
Market Context: Tech Weakness Weighs on Nasdaq
The Nasdaq sold off as chip stocks and mega-cap tech came under pressure. NVIDIA (NVDA) fell 1.6%, Microsoft (MSFT) dropped 1.8%, and Tesla (TSLA) declined 1.5%. On the positive side, Apple (AAPL) rose 0.9%, Meta (META) gained 1%, and Alphabet (GOOGL) added 1%.
The 10-year Treasury yield fell to 4.43%, while the VIX volatility index declined to 15.86 — signaling low near-term volatility expectations. The S&P 500 slipped 0.4% from yesterday's record close to 7,525.
IPO Market: Post-SpaceX Momentum Continues
This week's IPO calendar follows last week's record-breaking SpaceX (SPCX) IPO, which raised $75 billion at a $1.7 trillion valuation and closed its first trading day up 19%.
Two IPOs are scheduled for the current week:
- Kardigan (KARD) — a cardiovascular disease biotech advancing three late-stage candidates, including an oral cardiac myosin activator for genetic dilated cardiomyopathy. The company expects to raise $350 million at a $1.6 billion valuation.
- First Carolina Financial Services (FCBM) — a North Carolina-based community bank with $3.4 billion in total assets and 524,000 deposit accounts. The deal is set at $83 million with a $454 million market cap.
Doncasters Group, an aerospace and defense engine manufacturer, set terms for a $700 million US IPO — one of the largest industrial offerings this year.
On the filing front, two new SPACs filed today: OceanLight Acquisition ($100 million) and Yorkville International Capital ($200 million), which also priced.
Recent IPO Winners & Losers
Among last week's pricings, Parabilis Medicines (PBLS) — formerly FOG Pharmaceuticals — stood out with a 36% gain after upsizing its deal to $670 million at a $2.7 billion valuation. In contrast, ERock (EROC) — a natural gas power generation company serving data centers — tumbled 21% after reporting widening losses.
The Renaissance IPO Index is up 21.1% year-to-date, more than double the S&P 500's 8.6% return over the same period.
Why It Matters
The IPO market is experiencing a resurgence after two years of sluggish activity, with the SpaceX mega-deal opening the window for a diverse set of follow-on offerings across aerospace, biotech, and community banking. Meanwhile, early Q2 earnings suggest a mixed picture may be forming, particularly in consumer-facing sectors.
The Bottom Line
Investors are closely watching the evolving earnings season alongside the IPO calendar. This week's listings — particularly Kardigan and First Carolina Financial — will test whether IPO momentum can sustain beyond mega-cap deals.
